FG

Business Context and Reporting Period

Company: F&G Annuities & Life, Inc. (FGAL)

Filing Type: Form 10-Q (Quarterly Report)

Reporting Period: Quarter and six months ended June 30, 2026

Business Overview: FGAL is a majority-owned subsidiary of Fidelity National Financial, Inc. It provides insurance solutions including deferred annuities (fixed indexed and fixed rate), immediate annuities, indexed universal life (IUL) insurance, pension risk transfer (PRT) solutions, and funding agreements. The company operates through retail channels (agents, banks, broker-dealers) and institutional markets.

Recent Developments:

• Leadership Transition: Chris Blunt retired as CEO effective June 30, 2026. Conor Murphy assumed the role of CEO and President. Michael Bailey joined as CFO effective August 3, 2026.
• Divestiture: Completed the sale of F&G Life Re Ltd. to Ancient Financial Holdings, LP on March 1, 2026, recognizing a pre-tax gain of approximately $14 million.
• Stock Repurchase: Approved a new $100 million repurchase program in March 2026. Purchased $120 million of stock in the first six months of 2026.

Key Financial Metrics

Note: The filing does not provide a specific "profit margin" percentage; however, net earnings for the six months ended June 30, 2026, were $174 million on revenues of $2,608 million.

Material Changes vs. Prior Period

• Quarterly Loss vs. Prior Year Profit: The company reported a net loss of $75 million for the three months ended June 30, 2026, compared to net earnings of $42 million in the same period in 2025. This was primarily driven by a $94 million pre-tax loss, largely due to increased benefits and expenses ($1,515 million vs. $1,307 million) outpacing revenue growth.
• Strong Year-to-Date Performance: For the six months ended June 30, 2026, net earnings attributable to common shareholders were $163 million, a significant increase from $10 million in the prior year period. This improvement was driven by higher recognized gains ($258 million vs. a loss of $212 million) and increased interest and investment income ($1,441 million vs. $1,348 million).
• Revenue Composition: Life insurance premiums and other fees decreased to $873 million (six months 2026) from $1,097 million (six months 2025), reflecting lower PRT premiums due to transaction timing. However, recognized gains and losses improved significantly due to derivative performance and the sale of F&G Life Re.
• Investment Portfolio: Total investments increased to $70.28 billion from $69.44 billion at year-end 2025. The portfolio includes significant unrealized losses ($3.36 billion gross) primarily due to interest rate movements, though the company maintains a high credit quality portfolio (95% rated NAIC 1 or 2).

Guidance, Outlook, and Risks

Management Commentary: Management highlighted that while GAAP earnings were volatile due to market-related items (derivatives, embedded derivatives), Adjusted Net Earnings (ANE) attributable to common shareholders were $195 million for the six months ended June 30, 2026, compared to $194 million in the prior year. This metric excludes market volatility and non-recurring items to reflect underlying profitability.

Outlook and Trends:

• Interest Rate Environment: The company notes that rising interest rates increase the fair value of liabilities (embedded derivatives) but also increase investment income. The weighted-average crediting rate on fixed rate annuities was 4.81% as of June 30, 2026.
• Sales Trends: Net sales for the six months ended June 30, 2026, were $3.7 billion, down from $4.9 billion in the prior year, primarily due to lower opportunistic sales of MYGA and funding agreements, though core sales (indexed annuities, IUL, PRT) remained relatively stable.

Risks and Contingencies:

• Market Risk: Significant exposure to equity price volatility and interest rate changes affecting the fair value of embedded derivatives and market risk benefits (MRBs). A 100 basis point increase in interest rates would decrease the fair value of fixed maturity securities by approximately $3.4 billion.
• Reinsurance Concentration: Significant concentration of reinsurance risk with specific reinsurers (Aspida, Somerset, Everlake, Ancient Re, Fort Greene, Wilton Re). Failure of any of these entities could materially impact financial position.
• Legal Proceedings: Ongoing litigation regarding commission disputes (Insurance Distribution Consulting, LLC v. FGL Insurance) and data privacy claims related to the MOVEit software vulnerability. Management does not currently believe these will have a material adverse effect.
• Regulatory Capital: Certain subsidiaries rely on permitted statutory accounting practices to maintain minimum risk-based capital requirements.

Key Facts for Investor Verification

• Q2 2026 Loss Drivers: Verify the specific impact of "Benefits and other changes in policy reserves" ($1,149 million) and "Market risk benefit losses" ($32 million) on the Q2 net loss, as these were significantly higher than the prior year quarter.
• Derivative Hedging Effectiveness: Review the reconciliation between the change in fair value of equity options/futures (gains) and the change in fair value of indexed annuity embedded derivatives (liabilities) to assess hedging efficiency and basis risk.
• Reinsurance Counterparty Health: Monitor the financial strength ratings of key reinsurers (Aspida, Somerset, Everlake, Ancient Re) given the high concentration of reinsurance recoverables ($20.9 billion).
• Unrealized Investment Losses: Assess the sustainability of the $3.36 billion gross unrealized loss position in the investment portfolio and the adequacy of the $71 million allowance for expected credit losses on AFS securities.
• Adjusted Net Earnings (ANE): Compare GAAP net earnings to ANE ($195 million for six months 2026) to understand the volatility caused by fair value accounting for derivatives and embedded derivatives.
• Leadership Transition Impact: Monitor the execution of the new CEO (Conor Murphy) and CFO (Michael Bailey) strategy, particularly regarding capital allocation and expense management.